Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

About Newsroom Page 16

The Latest News From the Ivy Center

The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics. 

Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs. 

To contact the media relation team, call 602-406-7437 or email: [email protected]. 

Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog. 

Taxonomy Icon
  • April 8, 2019
  • Source: The Onco'Zine Brief
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain.
Taxonomy Icon
  • March 27, 2019
  • Source: Scientific American
In Bret Stetka's latest piece for the Scientific American, Dr. Nader Sanai weighs in on the challenges of treating glioblastoma and how our accelerated Phase 0/2 clinical trials are delivering new therapeutic options for patients facing the fight of their lives.
Taxonomy Icon
  • January 21, 2019
  • Source: KGUN 9
The Ivy Brain Tumor Center at Barrow Neurological Institute is taking a bold approach by using Phase 0 testing in patient clinical trials.
Taxonomy Icon
  • January 21, 2019
  • Source: ABC15
There's a glimmer of hope in treating the deadliest form of brain cancer, thanks to a drug trial happening right here in the Valley.
Taxonomy Icon
  • November 28, 2018
  • Source: Texoma's | KFDX 3
Senator John McCain recently died after fighting glioblastoma, the most aggressive and deadliest kind of brain tumor. Now, other patients whose brain tumors come back have a revolutionary new option for treatment.
Taxonomy Icon
  • November 27, 2018
A new Ivy Brain Tumor Center study finds that recently-approved drug ribociclib may be an important part of treatment for glioblastoma, one of the deadliest cancers in the world.
Taxonomy Icon
  • November 25, 2018
  • Source: The ASCO Post
The Ben and Catherine Ivy Foundation, in partnership with the Barrow Neurological Institute in Phoenix, has awarded a $50 million grant to establish a new translational science program focusing on early-phase, pharmacodynamic- and pharmacokinetic-driven clinical trials for aggressive brain tumors.
Taxonomy Icon
  • November 8, 2018
  • Source: WNDU | 16 News Now
In the last 30 years, a brain tumor expert says median survival has only increased by a few months. Now, a new brain tumor center program is fast-tracking patients into new therapies.
Taxonomy Icon
  • September 10, 2018
  • Source: Phoenix Business Journal
Thanks to a $50 million grant, Barrow Neurological Institute will create a new center to focus on finding a cure and improving outcomes for the deadliest form of brain cancer.
Taxonomy Icon
  • September 10, 2018
  • Source: Arizona Republic
With $50 million from a private foundation, Phoenix-based Barrow Neurological Institute announced Monday that it is opening a center to focus on improving brain-cancer outcomes through experimental clinical trials.